For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with John Cassidy, CEO of Cambridge Cancer Genomics. CCG is using liquid biopsy, genomics, and artificial intelligence to predict cancer disease progression and improve its treatment.
For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Kristen Fortney, founder and CEO of BioAge Labs. Kristen leads one of just a few companies focused explicitly on aging itself, rather than just the diseases for which aging puts people at greater risk.
For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Sam Cooper, cofounder and CEO of Phenomic AI. Sam and his team use machine learning for automated image analysis to study cell biology and screen drugs. But that’s just the beginning.
For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Shai Shen-Orr, chief scientist of CytoReason, about systems immunology, its potential in medicine, and how CytoReason applies artificial intelligence to make sense of the growing body of immune-related data.
For this episode of the Artificial Intelligence in Drug Discovery podcast, I spoke with Leila Pirhaji of ReviveMed about metabolomics for diagnosis and treatment, and how ReviveMed is using AI to realize its potential.
For this episode of the Artificial Intelligence in Drug Discovery podcast, I spoke with Mostapha Benhenda of Startcrowd about a controversial article critiquing several research labs and how the field evolved since he wrote it.
For this episode of the Artificial Intelligence in Drug Discovery podcast, I spoke with Mauro Cozzi, co-founder of Researchably. Learn how it got started, how it helps researchers find relevant literature faster, and the challenges they’re working to overcome to continue their growth.
For the inaugural episode of Artificial Intelligence in Drug Discovery, I spoke with Dekel Gelbman, CEO of FDNA. Listen now to learn what inspired their technology, the problems it solves, how it can help in the drug discovery process, and where FDNA plans to take it.
Artificial intelligence is widely adopted by e-commerce websites. Read about how AI can be used to improve reagent purchase to facilitate research discoveries.
We surveyed 330 scientists in December 2017 about artificial intelligence in drug discovery. See what we learned about adoption, barriers, and opportunities.